Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment

The nonvitamin K antagonist oral anticoagulants (NOACs), also referred to as direct oral anticoagulants (DOACs), dabigatran, apixaban, edoxaban, and rivaroxaban, have emerged as effective alternatives to vitamin K antagonists (VKAs) across several indications, including the prevention of stroke and...

Descripción completa

Detalles Bibliográficos
Autores principales: Turpie, Alexander G.G., Purdham, Daniel, Ciaccia, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562140/
https://www.ncbi.nlm.nih.gov/pubmed/28651452
http://dx.doi.org/10.1177/1753944717714921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562140/
https://www.ncbi.nlm.nih.gov/pubmed/28651452
http://dx.doi.org/10.1177/1753944717714921

Ejemplares similares